ICDcodes.org
FY2027

T80.82XDComplication of immune effector cellular therapy, subsequent encounter

Billable

Is T80.82XD billable?

Yes — T80.82XD is billable for FY2027. T80.82XD is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. T80.82XD may be submitted for encounters from October 1, 2026 through September 30, 2027.

T80.82XD at a glance

CodeT80.82XD
DescriptionComplication of immune effector cellular therapy, subsequent encounter
BillableYes
Code setICD-10-CM FY2027
Valid for encountersOctober 1, 2026 – September 30, 2027
7th character "D"subsequent encounter

What does the 7th character "D" mean in T80.82XD?

In T80.82XD, the 7th character D means subsequent encounter. The 7th character is required for T80.82XD to be a valid, complete code.

Same condition, different episode of care — switch the 7th character:

Which MS-DRGs does T80.82XD group to?

T80.82XD sits in MDC 23 and helps define the logic of 2 MS-DRGs (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.

  • 949Aftercare with CC/MCCmedical
  • 950Aftercare without CC/MCCmedical

How is T80.82XD listed in the Alphabetic Index?

The Alphabetic Index lists these routes under T80.82, the nearest indexed parent of T80.82XD. Use them to find the family, then select the specific code.

  • Complicationchimeric antigen receptorcell therapy (s) (from) (of)
  • ComplicationIECtherapy (s) (from) (of)
  • Complicationimmune effector cellulartherapy (s) (from) (of)

Use additional code

Report an additional code alongside T80.82XD to fully describe the condition. T80.82XD is sequenced first.

  • code to identify the specific complication, such as:
  • cytokine release syndrome (D89.83-)
  • immune effector cell-associated neurotoxicity syndrome (G92.0-)

Excludes2 — not included here

The conditions below are not part of T80.82XD, but a patient may have both at the same time. When documentation supports it, T80.82XD and the excluded code may both be reported.

  • adverse effect of immune checkpoint inhibitors and immunostimulant drugs (T45.AX5)
  • complication of bone marrow transplant (T86.0)
  • complication of stem cell transplant (T86.5)

Inclusion terms

Alternative wording in documentation that is classified to T80.82XD.

  • Complication of chimeric antigen receptor (CAR-T) cell therapy
  • Complication of IEC therapy

Use additional code — inherited from Chapter 19

Report an additional code alongside T80.82XD to fully describe the condition. T80.82XD is sequenced first.

  • code to identify any retained foreign body, if applicable (Z18.-)

Use additional code — inherited from T80-T88

Report an additional code alongside T80.82XD to fully describe the condition. T80.82XD is sequenced first.

  • code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
  • code(s) to identify the specified condition resulting from the complication
  • code to identify devices involved and details of circumstances (Y62-Y82)

Use additional code — inherited from T80.82

Report an additional code alongside T80.82XD to fully describe the condition. T80.82XD is sequenced first.

  • code to identify the specific complication, such as:
  • cytokine release syndrome (D89.83-)
  • immune effector cell-associated neurotoxicity syndrome (G92.0-)

Excludes2 — not included here — inherited from Chapter 19

The conditions below are not part of T80.82XD, but a patient may have both at the same time. When documentation supports it, T80.82XD and the excluded code may both be reported.

  • birth trauma (P10-P15)
  • obstetric trauma (O70-O71)

Excludes2 — not included here — inherited from T80-T88

The conditions below are not part of T80.82XD, but a patient may have both at the same time. When documentation supports it, T80.82XD and the excluded code may both be reported.

  • any encounters with medical care for postprocedural conditions in which no complications are present, such as:
  • artificial opening status (Z93.-)
  • closure of external stoma (Z43.-)
  • fitting and adjustment of external prosthetic device (Z44.-)
  • burns and corrosions from local applications and irradiation (T20-T32)
  • complications of surgical procedures during pregnancy, childbirth and the puerperium (O00-O9A)
  • mechanical complication of respirator [ventilator] (J95.850)
  • poisoning and toxic effects of drugs and chemicals (T36-T65 with fifth or sixth character 1-4 or 6)
  • postprocedural fever (R50.82)
  • specified complications classified elsewhere, such as:
  • cerebrospinal fluid leak from spinal puncture (G97.0)
  • colostomy malfunction (K94.0-)
  • disorders of fluid and electrolyte imbalance (E86-E87)
  • functional disturbances following cardiac surgery (I97.0-I97.1)
  • intraoperative and postprocedural complications of specified body systems (D78.-, E36.-, E89.-, G97.3-, G97.4, H59.3-, H59.-, H95.2-, H95.3, I97.4-, I97.5, J95.6-, J95.7, K91.6-, L76.-, M96.-, N99.-)
  • ostomy complications (J95.0-, K94.-, N99.5-)
  • postgastric surgery syndromes (K91.1)
  • postlaminectomy syndrome NEC (M96.1)
  • postmastectomy lymphedema syndrome (I97.2)
  • postsurgical blind-loop syndrome (K91.2)
  • ventilator associated pneumonia (J95.851)

Excludes2 — not included here — inherited from T80

The conditions below are not part of T80.82XD, but a patient may have both at the same time. When documentation supports it, T80.82XD and the excluded code may both be reported.

  • bone marrow transplant rejection (T86.01)
  • febrile nonhemolytic transfusion reaction (R50.84)
  • fluid overload due to transfusion (E87.71)
  • posttransfusion purpura (D69.51)
  • transfusion associated circulatory overload (TACO) (E87.71)
  • transfusion (red blood cell) associated hemochromatosis (E83.111)
  • transfusion related acute lung injury (TRALI) (J95.84)

Excludes2 — not included here — inherited from T80.82

The conditions below are not part of T80.82XD, but a patient may have both at the same time. When documentation supports it, T80.82XD and the excluded code may both be reported.

  • adverse effect of immune checkpoint inhibitors and immunostimulant drugs (T45.AX5)
  • complication of bone marrow transplant (T86.0)
  • complication of stem cell transplant (T86.5)

How long has T80.82XD existed?

T80.82XD first appears in FY2022.

Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.